Kopin Tan has taken over the weekly Trader column duties from Mike Santoli:
"THE PROGRESSION OF ILLNESS FOLLOWS a typical arc: Symptoms surface. A diagnosis is rendered. Then comes a prescribed remedy and, possibly, recovery.
But for investors who had been fretting about the
contagious spread of mortgage delinquencies, a benign economic
prognosis from the Federal Reserve last week was all it took to feel
sprightlier — and drive up stocks prices. In holding interest rates
steady at 5.25%, the Fed also dispensed with a customary threat to
tighten monetary policy as needed. The famous phrase’s conspicuous
absence was interpreted, rightly or wrongly, as a willingness to begin
cutting interest rates soon.
That mere whiff of a possible prescription was
enough to send this patient into recovery. Stocks raced to their
biggest one-day gain this year once the Fed statement hit the tape. The
broad rally lifted all sectors, with financial stocks leading the way.
Cash flow into U.S. mutual funds eventually topped $2.2 billion on the
week — the first time since July 2005, according to Banc of America
Securities, that domestic-equity funds hauled in more cash than their
I had a few choice words in the column:
Whether the market’s
suddenly improved sense of well-being is warranted remains to be seen.
Barry Ritholtz, chief market strategist at Ritholtz Research &
Analytics, likens investors’ clamor for a possible rate cut to "praying
"The Fed begins cutting rates for two possible
reasons — when it’s apparent that inflation is no longer a problem,
which isn’t the case here, or when economic growth slows dangerously,"
he says. Steady inflation gauges and firm commodity prices — crude oil
is at a three-month high, and copper prices are up 12% this month —
suggest inflation remains a threat. So was Dr. Bernanke more concerned
about the economy than he lets on?
You know what I think on this already . . .
The Patient’s Improving, For Now
Barron’s THE TRADER, March 26, 2007